Patent · US Active

Compositions of selenoorganic compounds and methods of use thereof

US10201558B2 · kind B2 · utility

1Cited by
4References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2015
Grant dateFeb 12, 2019
Priority date
Expiry dateMay 25, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/7064
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application relates to compositions comprising selenium compounds, such as 5′-Methylselenoadenosine, a compound of Formula (I), and combinations thereof, and methods of using the same for inhibiting β amyloid aggregation, ApoE4 expression, p38 or Tau protein phosphorylation, or increasing Neprilysin and Insulin Degrading Enzyme expression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.